Press release
NK Cell Therapy Pipeline 2024 | ImmunityBio, Cantargia, CureTech, Dynavax, Cellid, Abivax, Affimed, Celularity, Glycostem Therapeutics (IPD Therapeutic), SYNIMMUNE, Celyad, Acepodia, Allife Medical Sc
Discover the latest drugs and treatment options in the NK Cell Therapy Pipeline. Dive into DelveInsight's comprehensive report today! @ NK Cell Therapy Pipeline Outlook [https://www.delveinsight.com/sample-request/nk-cell-therapy-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the NK Cell Therapy Pipeline Report
* June 2024:- New Approaches to Neuroblastoma Therapy Consortium- Phase II Study of Ex-Vivo Expanded Allogeneic Universal Donor TGFi NK Cell Infusions in Combination With Temozolomide, Irinotecan, Dinutuximab, and Sargramostim in Patients With Relapsed or Refractory Neuroblastoma The STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
* DelveInsight's NK Cell Therapy pipeline report depicts a robust space with 100+ active players working to develop 185+ pipeline therapies for NK Cell Therapy treatment.
* The leading companies working in the NK Cell Therapy Market include ImmunityBio, Cantargia, CureTech, Dynavax, Cellid, Abivax, Affimed, Celularity, Glycostem Therapeutics (IPD Therapeutic), SYNIMMUNE, Celyad, Acepodia, Allife Medical Science and Technology, Bright Path Biotherapeutics, Cytovia Therapeutics, CytoImmune Therapeutics, Exacis Biotherapeutics, Novocellbio, Kuur Therapeutics (Former name: Cell Medica), Fate Therapeutics, Feldan Therapeutics, iCell Gene Therapeutics, Innate Pharma, Nkarta Therapeutics, Surface Oncology, Kiadis Pharma, Vycellix, INmune Bio, CiMass, Glycostem, Five Prime Therapeutics, Multimmune GmbH, Ambicion, Bellicum Pharmaceuticals, CARsgen therapeutics, Kuur Therapeutics, Celyad, Dragonfly Therapeutics, GamidaCell, NantKwest, Asclepius Technology Company, AffimedTherapeutics, Apceth Biopharma, Zelluna Immunotherapy, Catamaran Bio, ONK Therapeutics, Orgenesis, Navrogen, NKMAX, Nektar Therapeutics, Affimed Therapeutics, HerbiCell, Bristol-Myers Squibb, CellProtect Nordic Pharmaceuticals, CytoVac, Green Cross Corporation, NantKwest, PersonGen BioTherapeutics (Suzhou), GT Biopharma (formerly Oxis International Inc.), Nektar Therapeutics, Artiva Biotherapeutics, Senti Biosciences, oNKo-innate, Affimed Therapeutics, Agenus, Chongqing Sidemu Biotechnology, NKGen Biotech, Caribou Biosciences, Gamida-Cell, Wugen, Molmed, Century Therapeutics, KSQ Therapeutics, GT Biopharma, Shoreline Biosciences, Indapta Therapeutics, HebeCell, Sorrento therapeutics, Appia Bio, Cellatoz Therapeutics, Sanofi, Glycotype, CiMaas, CoImmune, Editas Medicine, Healios, Chimeric Therapeutics, Rubius Therapeutics, Oncternal Therapeutics, MedXCell, MiNK Therapeutics, Phio Pharmaceuticals, Biohaven Pharmaceuticals, Lava therapeutics, Allogene Therapeutics/Notch Therapeutics, Onward therapeutics, Miltenyi Biotech, and others.
* Promising NK Cell Therapy Pipeline Therapies in the various stages of development include Fludarabine, Cytoxan, Vax-NK/HCC, FATE-NK100, Cetuximab, Trastuzumab, ACE1702, Cyclophosphamide, and others.
Stay ahead with the most recent pipeline outlook for NK Cell Therapy. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ NK Cell Therapy Treatment Drugs [https://www.delveinsight.com/sample-request/nk-cell-therapy-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
NK Cell Therapy Emerging Drugs Profile
- NKTR-214: Nektar therapeutics
- Monalizumab: Innate Pharma
- Bemarituzumab: Five Prime Therapeutics
- ALT 803: ImmunityBio
- CellProtect: XNK Therapeutics
- K-NK002: Kiadis Pharma
- NK-92: ImmunityBio
- WU-NK-101: Wugen
- Anti-CD33 CAR-NK cells: PersonGen BioTherapeutics
- ALECSAT: CytoVac
NK Cell Therapy Pipeline Therapeutics Assessment
There are approx. 100+ key companies which are developing the therapies for Natural Killer (NK) cell therapy. The NK Cell Therapy companies which have their Natural Killer (NK) cell therapy drug candidates in the most advanced stage, i.e. Phase III include, Nektar therapeutics.
Explore groundbreaking therapies and clinical trials in the NK Cell Therapy Pipeline. Access DelveInsight's detailed report now! @ New NK Cell Therapy Drugs [https://www.delveinsight.com/sample-request/nk-cell-therapy-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
DelveInsight's NK Cell Therapy pipeline report covers around 185+ products under different phases of clinical development like
- Late-stage products (Phase III and
- Mid-stage products (Phase II and
- Early-stage products (Phase I/II and Phase I) along with the details of
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
- Route of Administration
NK Cell Therapy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration
- Infusion
- Intradermal
- Intramuscular
- Intranasal
- Intravaginal
- Oral
- Parenteral
- Subcutaneous
- Topical.
- Molecule Type
NK Cell Therapy Pipeline Products have been categorized under various Molecule types such as
- Vaccines
- Monoclonal Antibody
- Peptides
- Polymer
- Small molecule
- Product Type
Unveil the future of NK Cell Therapy Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight's expert analysis @ NK Cell Therapy Market Drivers and Barriers [https://www.delveinsight.com/sample-request/nk-cell-therapy-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the NK Cell Therapy Pipeline Report
- Coverage- Global
- NK Cell Therapy Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
- NK Cell Therapy Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
- NK Cell Therapy Companies- ImmunityBio, Cantargia, CureTech, Dynavax, Cellid, Abivax, Affimed, Celularity, Glycostem Therapeutics (IPD Therapeutic), SYNIMMUNE, Celyad, Acepodia, Allife Medical Science and Technology, Bright Path Biotherapeutics, Cytovia Therapeutics, CytoImmune Therapeutics, Exacis Biotherapeutics, Novocellbio, Kuur Therapeutics (Former name: Cell Medica), Fate Therapeutics, Feldan Therapeutics, iCell Gene Therapeutics, Innate Pharma, Nkarta Therapeutics, Surface Oncology, Kiadis Pharma, Vycellix, INmune Bio, CiMass, Glycostem, Five Prime Therapeutics, Multimmune GmbH, Ambicion, Bellicum Pharmaceuticals, CARsgen therapeutics, Kuur Therapeutics, Celyad, Dragonfly Therapeutics, GamidaCell, NantKwest, Asclepius Technology Company, AffimedTherapeutics, Apceth Biopharma, Zelluna Immunotherapy, Catamaran Bio, ONK Therapeutics, Orgenesis, Navrogen, NKMAX, Nektar Therapeutics, Affimed Therapeutics, HerbiCell, Bristol-Myers Squibb, CellProtect Nordic Pharmaceuticals, CytoVac, Green Cross Corporation, NantKwest, PersonGen BioTherapeutics (Suzhou), GT Biopharma (formerly Oxis International Inc.), Nektar Therapeutics, Artiva Biotherapeutics, Senti Biosciences, oNKo-innate, Affimed Therapeutics, Agenus, Chongqing Sidemu Biotechnology, NKGen Biotech, Caribou Biosciences, Gamida-Cell, Wugen, Molmed, Century Therapeutics, KSQ Therapeutics, GT Biopharma, Shoreline Biosciences, Indapta Therapeutics, HebeCell, Sorrento therapeutics, Appia Bio, Cellatoz Therapeutics, Sanofi, Glycotype, CiMaas, CoImmune, Editas Medicine, Healios, Chimeric Therapeutics, Rubius Therapeutics, Oncternal Therapeutics, MedXCell, MiNK Therapeutics, Phio Pharmaceuticals, Biohaven Pharmaceuticals, Lava therapeutics, Allogene Therapeutics/Notch Therapeutics, Onward therapeutics, Miltenyi Biotech, and others.
- NK Cell Therapy Pipeline Therapies- Fludarabine, Cytoxan, Vax-NK/HCC, FATE-NK100, Cetuximab, Trastuzumab, ACE1702, Cyclophosphamide, and others.
Get the latest on NK Cell Therapy Therapies and clinical trials. Download DelveInsight's in-depth pipeline report today! @ NK Cell Therapy Companies, Key Products and Unmet Needs [https://www.delveinsight.com/sample-request/nk-cell-therapy-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Introduction
2. Executive Summary
3. Natural Killer (NK) cell therapy: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. NKTR-214: Nektar therapeutics
8. Drug profiles in the detailed report.....
9. Mid Stage Products (Phase II)
10. CellProtect: XNK Therapeutics
11. Drug profiles in the detailed report.....
12. Early stage products (Phase I/II)
13. Anti-CD33 CAR-NK cells: PersonGen BioTherapeutics
14. Drug profiles in the detailed report.....
15. Inactive Products
16. Natural Killer (NK) cell therapy Key Companies
17. Natural Killer (NK) cell therapy Key Products
18. Natural Killer (NK) cell therapy- Unmet Needs
19. Natural Killer (NK) cell therapy- Market Drivers and Barriers
20. Natural Killer (NK) cell therapy- Future Perspectives and Conclusion
21. Natural Killer (NK) cell therapy Analyst Views
22. Natural Killer (NK) cell therapy Key Companies
23. Appendix
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=nk-cell-therapy-pipeline-2024-immunitybio-cantargia-curetech-dynavax-cellid-abivax-affimed-celularity-glycostem-therapeutics-ipd-therapeutic-synimmune-celyad-acepodia-allife-medical-sc]
Phone: +14699457679
Address:304 S. Jones Blvd #2432,
City: Las Vegas
State: United States
Country: India
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NK Cell Therapy Pipeline 2024 | ImmunityBio, Cantargia, CureTech, Dynavax, Cellid, Abivax, Affimed, Celularity, Glycostem Therapeutics (IPD Therapeutic), SYNIMMUNE, Celyad, Acepodia, Allife Medical Sc here
News-ID: 3577570 • Views: …
More Releases from ABNewswire
Eloy the Super Morrocoy: Inspiring Children's Book Now Available in English
Eloy the Super Morrocoy by Nathalia Brines is an inspiring children's book introducing Eloy, a tortoise with superhero dreams. Originally honored at the 2023 International Latino Book Awards, the book blends Venezuelan fauna and folklore with universal values of empathy, resilience, and inclusion. Available in English worldwide, it encourages children and families to embrace courage, kindness, and perseverance while celebrating Hispanic heritage
26 September, 2025 - Award-winning author and educator Nathalia…
BustNMoves Moving Company Strengthens Presence in Pocatello with Premium Moving …
Pocatello, ID - Moving can be stressful, but residents and businesses in Pocatello now have a trusted partner in BustNMoves Moving Company [https://bustnmoves.com/movers/pocatello-id/]. Known for its personalized approach, professional team, and commitment to customer satisfaction, BustNMoves delivers efficient, reliable, and safe moving services that make every relocation smooth and worry-free.
Local Expertise with a Personal Touch
Founded with a vision to redefine the moving experience, BustNMoves Moving Company - Pocatello Movers [https://www.google.com/maps?cid=13317853229233714232]…
Bodydynamics Shares Expert Tips on Documenting Injuries for a Successful WSIB Ph …
If you've suffered an injury at work and are seeking physiotherapy coverage through the Workplace Safety and Insurance Board (WSIB), proper documentation is essential. Your claim's success can heavily rely on how well you record every step of your injury and recovery. Whether you're dealing with a sprain, strain, or other work-related injury, showing the full extent of your condition is key to getting the support you need.
In this guide,…
Marketplace Dentistry Shares Expert Tips to Spot and Prevent Dental Implant Comp …
Dental implants have become a popular solution for replacing missing teeth, offering a natural look and feel. However, like any medical procedure, complications can occur, making it crucial to understand how to avoid or address potential issues. By recognizing early signs of problems and following proper aftercare, you can increase the lifespan of your implants and maintain your oral health.
The key to preventing complications with dental implants lies in vigilance…
More Releases for Therapeutic
Exosome Therapeutic Market : Detailed Overview
Introduction:
The exosome therapeutic market is a rapidly emerging segment in the field of regenerative medicine and drug delivery. Exosomes are extracellular vesicles naturally released by cells that play a crucial role in cell communication and genetic material transfer. They have gained attention for their potential applications in treating various diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions. As a novel therapeutic platform, exosomes provide significant advantages such as low immunogenicity,…
Parkinson's Disease Therapeutic Market Hope for Patients: The Parkinson's Diseas …
Parkinson's Disease Therapeutic Market worth $6.51 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Parkinson's Disease Therapeutic Market - (By Drugs (Carbidopa-levodopa, Dopamine agonists, Mao-b inhibitors, COMT inhibitors, Anticholinergics, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), By Brand (Branded, Generics), By Route of Administration (Oral, Injectable, Intestinal Infusion, Subcutaneous, Others)),…
Global Remote Therapeutic Monitoring Market
According to a new market research report published by Global Market Estimates, the Global Remote Therapeutic Monitoring Market is projected to grow at a CAGR of 17.4% from 2023 to 2028.
Medsien, Intellihinc, Zimmer Biomet, Owlytics Healthcare, Limber Health, Medistics, RxCap, Propeller Health, HealthArc, CENSON Health, and B Castle Smith & Co., are some of the key players in the remote therapeutic monitoring market.
Browse 147 Market Data Tables and 115…
Europe Digital Therapeutic (DTx) Market
Europe Digital Therapeutic (DTx) Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Europe Digital Therapeutic (DTx) Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Europe Digital Therapeutic (DTx) market examines the primary segments of the market. This intelligent study provides historical data from forecast.It also provides the details such as whether the customers…
Recombinant Therapeutic Antibodies and Proteins Market continues to expand with …
Recombinant therapeutic protein drugs are an important class of medicines, which helps patients in need of novel therapies. Recently approved recombinant protein therapeutics have been developed to treat a wide variety of clinical indications, including cancers, inflammation/autoimmunity, genetic disorders, and exposure to infectious agents. The latest advancements in protein-engineering technologies have allowed drug manufacturers and developers to adjust desirable functional characteristics of proteins of interest maintaining product efficacy. Protein-based therapies…
Therapeutic Vaccine Market 2020 - 2028 Top Companies Agenus Inc., Argos Therapeu …
This detailed market study covers therapeutic vaccine market growth potentials which can assist the stake holders to understand key trends and prospects in therapeutic vaccine market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
